Últimos tuits de @sanoysalvoblog

Web de interés: Sano y salvo Gracias @docenciacalvia  @sanoysalvoblog  http://t.co/sHDjQPMGmf
— Txema Coll (@txemacoll) June 22, 2013

(BMJ) Restructuring health systems for an era of prolonged austerity: an essay by Richard B Saltman and Zachary Cahn http://t.co/LojmSuR3uU
— Sano y salvo (@sanoysalvoblog) June 24, 2013

The science of human factors in patient safety: here's an article that distinguishes fact from fiction. Open access.http://t.co/RM7LlWshlT
— BMJ Quality & Safety (@BMJ_Qual_Saf) June 23, 2013

(UKMi) Is there a suitable vitamin D product for a patient with a peanut or soya allergy? http://t.co/NeljS80GM0#PtSafety#AdverseEffects
— Sano y salvo (@sanoysalvoblog) June 24, 2013

What is the clinical significance of potential drug interactions with anaesthetic preparations used in dentistry? http://t.co/l7PF8tE8WS
— Sano y salvo (@sanoysalvoblog) June 24, 2013

Pese a las especificaciones de CONSORT la información sobre EAs en los ECAs sigue siendo pobre... #SegPac
— X.M. Meijome (@EnferEvidente) June 24, 2013

(CIMUM COL) La EMA emite seis estrategias para abordar los errores de medicación http://t.co/N3v7DUBp3z) #SegPac
— Sano y salvo (@sanoysalvoblog) June 25, 2013

(BMJ Letter) Statins are not bad medicine but their misuse is http://t.co/DQyktViZNH#PtSafety
— Sano y salvo (@sanoysalvoblog) June 25, 2013

(BMJ) Excess mortality associated with diabetes is falling, study shows http://t.co/sOAPbQMTyl#PtSafety
— Sano y salvo (@sanoysalvoblog) June 25, 2013

Prevención de errores de medicación: recomendaciones de la EMA. Un paso con ausencias como la #isoaparienciahttp://t.co/DCBfn9f67A  #SegPac
— Sano y salvo (@sanoysalvoblog) June 26, 2013

Calcitonina: intervención para mejorar la seguridad del paciente y la eficiencia de la prescripción http://t.co/AjWAOujov2#SegPac
— Sano y salvo (@sanoysalvoblog) June 26, 2013

Strategies to prevent medication errors and adverse drug events. #AHRQ Patient Safety Primers: http://t.co/OProVp5UTE#PtSafety
— Sano y salvo (@sanoysalvoblog) June 26, 2013

(BMJ) EMA consults public on plan to increase transparency of drug trial data http://t.co/tv2r8RGCWO#AllTrials#PtSafety
— Sano y salvo (@sanoysalvoblog) June 26, 2013

ADA/EASD Recommendations Concerning the Use of Incretin Therapy and Pancreatic Disease http://t.co/s2mDgp8kod#PtSafety
— Sano y salvo (@sanoysalvoblog) June 27, 2013

@je_pala@Lalospi@AEGRIS2 Friends, if you want to know more, please read:  http://t.co/a3jjG7HopK AND http://t.co/mb6eYtEOb4#secondvictim
— Kris Vanhaecht (@krisvanhaecht) June 27, 2013

La deprescripción como herramienta para el uso seguro del medicamento (vídeo) http://t.co/vKuuZsQuul por @enriquegavilan#SegPac
— Sano y salvo (@sanoysalvoblog) June 27, 2013

More sleep urged for residency doctors by @david_andreattahttp://t.co/TddlwsCq00 via @globeandmail#cdnhealth#ptsafety#meded
— André Picard (@picardonhealth) June 27, 2013

(EMA) New restrictions on use of medicines containing ergot derivatives http://t.co/acgtJ0cV5l#PtSafety
— Sano y salvo (@sanoysalvoblog) June 28, 2013

CMDh has endorsed PRAC recommendation on restrictions on use of #codeine for pain relief in children: http://t.co/lLAnnWuENi
— EMA (@EMA_News) June 28, 2013

CMDh has endorsed PRAC recommendation on new safety advice for #diclofenac to minimise cardiovascular risks: http://t.co/lppIobjNuB
— EMA (@EMA_News) June 28, 2013

(MHRA) Oral retinoids: pregnancy prevention—reminder of measures to minimise teratogenic risk http://t.co/sUFIy9Wjud#PtSafety
— Sano y salvo (@sanoysalvoblog) June 28, 2013

Grupo de defensa de la ISDB o cómo aprender a hacer lobby http://t.co/9rohOoOtsr#AllTrials#NoGracias#SegPac
— Sano y salvo (@sanoysalvoblog) June 28, 2013

US Study Shows Increased Rate of Liver Injury Due to Prescription and OTC Drugs http://t.co/858Oc8cNfx#PtSafety
— Sano y salvo (@sanoysalvoblog) June 28, 2013

(AAFP) Reducing the Risk of Adverse Drug Events in Older Adults https://t.co/c49FgVL8OG vía @velezmeca#PtSafety
— Sano y salvo (@sanoysalvoblog) June 28, 2013

Manejo de la intolerancia a estatinas, por RxFiles http://t.co/MpewmOkXr2 vía @JesusmRedondo  #SegPac
— Sano y salvo (@sanoysalvoblog) June 29, 2013

Soluciones para perfusión que contienen hidroxietil-almidón: revisión del balance beneficio-riesgo http://t.co/OnJtEhb0bT
— AEMPS (@AEMPSGOB) June 18, 2013

RT @Olguitxi Suspension definitiva de Hidroxietilalmidon 6% en UK https://t.co/sZyg8ytAZz#SegPac#UrgenciasAP
— Sano y salvo (@sanoysalvoblog) June 29, 2013

Ese terrible momento en el que te das cuenta de que has cometido un error de dispensación http://t.co/smWr5iR0Fb vía @Mavegare#SegPac
— Sano y salvo (@sanoysalvoblog) June 29, 2013

@annapitarch Gracias por la mención a Sano y salvo en http://t.co/hqKpWTeVXE. El inicio del blog de @Sefap_FAP, una excelente noticia
— Sano y salvo (@sanoysalvoblog) June 30, 2013

(El Gerente De Mediado) Cuidado con el leopardo http://t.co/jNO83dkiCo#SegPac
— Sano y salvo (@sanoysalvoblog) July 1, 2013

Vitamin D: When it helps, when it harms http://t.co/K03QZSwc3e#PtSafety
— Sano y salvo (@sanoysalvoblog) July 1, 2013

The AFP Community Blog: Another strike against NSAIDs? http://t.co/ZnRAbD4BfG#PtSafety
— Sano y salvo (@sanoysalvoblog) July 1, 2013

Percepción de la cultura de #SegPac#Ptsafety entre estudiantes últimos cursos http://t.co/FZOyceHq9f
— AEGRIS (@AEGRIS2) June 30, 2013

AEMPS: Derivados ergóticos y riesgo de fibrosis y ergotismo: restricción de indicaciones http://t.co/Cijg4mTkDX#SegPac
— Sano y salvo (@sanoysalvoblog) July 2, 2013

50% of adverse events in home care are deemed preventable.  #safetyathome#ptsafety - http://t.co/tmkXeoCHkr
— CPSI - ICSP (@Patient_Safety) July 2, 2013

Nueva convocatoria Curso Experto en Seguridad del Paciente http://t.co/ppm17wxdOC@uned
— Seguridad Paciente (@seguridadpacien) July 2, 2013

“@FDAMedWatch: Olmesartan Medoxomil: Drug Safety Communication- Label Changes To Include Sprue-Like Enteropathy http://t.co/53dY0ItrcX#FDA”
— Sano y salvo (@sanoysalvoblog) July 3, 2013

Crecen un 400% las muertes por abuso de analgésicos opioides en EEUU http://t.co/DrKoGrHT6r#SegPac
— Sano y salvo (@sanoysalvoblog) July 3, 2013

BMJ  launches Overdiagnosis series & editorial just out : "Too much medicine is harming both the sick and well." http://t.co/jseRxD9SWM  BMJ
— Ray Moynihan (@raymoynihan) July 3, 2013

AHRQ: Perspectives on Safety > Update on Safety Culture http://t.co/3T4xc2ax3K#PtSafety
— Sano y salvo (@sanoysalvoblog) July 4, 2013

AHRQ: Perspectives on Safety > In Conversation with…J. Bryan Sexton, PhD, MA (2006) http://t.co/WZea71yyz3#PtSafety
— Sano y salvo (@sanoysalvoblog) July 4, 2013

Prescrire. Do not use drugs to prevent onset of lactation http://t.co/CtUrcUPPxv#PtSafety
— Sano y salvo (@sanoysalvoblog) July 4, 2013

Prescrire International: Quetiapine and cardiac muscle disorders http://t.co/NxaYqOzzhj#PtSafety
— Sano y salvo (@sanoysalvoblog) July 4, 2013

EU Clinical Trials Regulation: towards a model that meets real public health needs http://t.co/cYktfGA0Im#AllTrials#PtSafety
— Sano y salvo (@sanoysalvoblog) July 4, 2013

Información sobre el buen uso de los medicamentos en caso de ola de calor. AEMPS 2013: Como todos los ... http://t.co/2hS6O0ZiED#SegPac
— Sano y salvo (@sanoysalvoblog) July 5, 2013

"@EvidBaseMed_BMJ: Deciding when to stop: towards evidence-based deprescribing of drugs in older populations http://t.co/RwyO0jZ4wy"
— Sano y salvo (@sanoysalvoblog) July 5, 2013

“@JesusmRedondo: AINEs y progresión de enfermedad renal crónica:no parece que sea clara la relacion. http://t.co/XGdF5aqBqv” #SegPac
— Sano y salvo (@sanoysalvoblog) July 5, 2013

Medication safety: opening up the black box. BMJ Qual Saf. Editorial http://t.co/h7yyxnQzPC#PtSafety
— Sano y salvo (@sanoysalvoblog) July 6, 2013

System barriers and resilient actions of primary care providers in the diagnostic evaluation of cancer http://t.co/NrI15BeH8V#PtSafety
— Sano y salvo (@sanoysalvoblog) July 6, 2013

Human factors and ergonomics as a patient safety practice. BMJ Qual Saf. Systematic review http://t.co/wZxp3rTvVR#PtSafety
— Sano y salvo (@sanoysalvoblog) July 6, 2013

Educational agenda for diagnostic error reduction among students, residents and practising physicians http://t.co/H0cqtPrWnW#PtSafety
— Sano y salvo (@sanoysalvoblog) July 6, 2013

Novetats CAMFiC is out! http://t.co/3gkn9kdYkK▸ Top stories today via @joseavil@sanoysalvoblog@jvalaball
— CAMFiC (@camfic) July 7, 2013

Study suggests that ACEi initiation increases the risk of developing UTIs (drug Safety) http://t.co/aSfiBtehE4#PtSafety
— Sano y salvo (@sanoysalvoblog) July 7, 2013

(e-butlletí groc) Multa por campaña de desinformación sobre los genéricos de clopidogrel http://t.co/Ak2miXo0BB
— Sano y salvo (@sanoysalvoblog) July 7, 2013

Clásicos bajo revisión: diclofenaco, codeina, ergotamínicos, hidroxietil-almidón http://t.co/7Dq54yGNx9
— hemosleido (@hemosleido) July 3, 2013

Effectiveness of safety alerts in electronic patient medication record systems at the point of pharmacy order entry http://t.co/iIkt2FecqS
— Sano y salvo (@sanoysalvoblog) July 7, 2013

La crisis económica y la seguridad de los pacientes; una visión personal en el blog "sálvese quién deba": recortes... http://t.co/GPCbqxUiyp
— AEGRIS (@AEGRIS2) July 7, 2013

Nursing a safer future: how #nurses are using proactive approaches to manage #PtSafetyhttp://t.co/LjSOmrHGZA  @NursingTimes@HealthFdn
— Sano y salvo (@sanoysalvoblog) July 7, 2013

RT @angel_h_merino Combinación de antibióticos: Vive la résistance! http://t.co/7hetSbSSbx… #SegPac vía @FarmaciaOesteAP
— Sano y salvo (@sanoysalvoblog) July 7, 2013

“@ernestob: Lectura ⇧ recomendable➔De la parsimonía en medicina http://t.co/5HZ8Iv3rhx Reflexiones contra una medicina de excesos” #SegPac
— Sano y salvo (@sanoysalvoblog) July 7, 2013